[go: up one dir, main page]

NO20073213L - Fremgangsmate for fremstilling av tiofenglykosidderivater - Google Patents

Fremgangsmate for fremstilling av tiofenglykosidderivater

Info

Publication number
NO20073213L
NO20073213L NO20073213A NO20073213A NO20073213L NO 20073213 L NO20073213 L NO 20073213L NO 20073213 A NO20073213 A NO 20073213A NO 20073213 A NO20073213 A NO 20073213A NO 20073213 L NO20073213 L NO 20073213L
Authority
NO
Norway
Prior art keywords
preparation
glycoside derivatives
thiophene
thiophene glycoside
aryl
Prior art date
Application number
NO20073213A
Other languages
English (en)
Inventor
Volker Derdau
Lars Bierer
Michael Kossenjans
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20073213L publication Critical patent/NO20073213L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det beskrives en fremgangsmåte for fremstilling av tiofenglykosidderivater med den generelle formel (I), der: Y er hydrogen eller alkyl; R1 er alkyl, hvorved hydrogenene kan være substituert med fluor eller aryl, og aryl også kan inneholde heteroatomer; og R2 er hydrogen, Cl, Br eller 1.
NO20073213A 2004-12-22 2007-06-22 Fremgangsmate for fremstilling av tiofenglykosidderivater NO20073213L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004063099A DE102004063099B4 (de) 2004-12-22 2004-12-22 Verfahren zur Herstellung von Thiophenglycosidderivaten
PCT/EP2005/013158 WO2006072334A2 (de) 2004-12-22 2005-12-08 Verfahren zur herstellung von thiophenglycosidderivaten

Publications (1)

Publication Number Publication Date
NO20073213L true NO20073213L (no) 2007-09-19

Family

ID=36599271

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073213A NO20073213L (no) 2004-12-22 2007-06-22 Fremgangsmate for fremstilling av tiofenglykosidderivater

Country Status (29)

Country Link
US (1) US20080207882A1 (no)
EP (1) EP1888613B1 (no)
JP (1) JP2008524272A (no)
KR (1) KR20070089946A (no)
CN (1) CN101080416A (no)
AR (1) AR052272A1 (no)
AT (1) ATE415407T1 (no)
AU (1) AU2005324187A1 (no)
BR (1) BRPI0519438A2 (no)
CA (1) CA2591114A1 (no)
CL (1) CL2008002563A1 (no)
CY (1) CY1108819T1 (no)
DE (2) DE102004063099B4 (no)
DK (1) DK1888613T3 (no)
ES (1) ES2318574T3 (no)
HR (1) HRP20090105T3 (no)
IL (1) IL183806A0 (no)
MA (1) MA29111B1 (no)
NO (1) NO20073213L (no)
NZ (1) NZ555591A (no)
PL (1) PL1888613T3 (no)
PT (1) PT1888613E (no)
RS (1) RS50726B (no)
RU (1) RU2394835C2 (no)
SI (1) SI1888613T1 (no)
TW (1) TW200635940A (no)
UY (1) UY29306A1 (no)
WO (1) WO2006072334A2 (no)
ZA (1) ZA200704028B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20090938A1 (es) 2007-08-16 2009-08-08 Boehringer Ingelheim Int Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo
US20110046076A1 (en) 2009-02-13 2011-02-24 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
UY33937A (es) 2011-03-07 2012-09-28 Boehringer Ingelheim Int Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994019360A1 (en) * 1993-02-23 1994-09-01 The Trustees Of Princeton University Solution and solid-phase formation of glycosidic linkages
DE10231370B4 (de) * 2002-07-11 2006-04-06 Sanofi-Aventis Deutschland Gmbh Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel

Also Published As

Publication number Publication date
ATE415407T1 (de) 2008-12-15
AR052272A1 (es) 2007-03-07
DE102004063099B4 (de) 2009-02-12
NZ555591A (en) 2009-07-31
TW200635940A (en) 2006-10-16
JP2008524272A (ja) 2008-07-10
CY1108819T1 (el) 2014-04-09
ZA200704028B (en) 2008-08-27
SI1888613T1 (sl) 2009-04-30
DE502005006107D1 (de) 2009-01-08
BRPI0519438A2 (pt) 2009-01-20
ES2318574T3 (es) 2009-05-01
CA2591114A1 (en) 2006-07-13
US20080207882A1 (en) 2008-08-28
DE102004063099A1 (de) 2006-07-13
IL183806A0 (en) 2007-10-31
PL1888613T3 (pl) 2009-04-30
WO2006072334A3 (de) 2007-06-07
CN101080416A (zh) 2007-11-28
WO2006072334A2 (de) 2006-07-13
CL2008002563A1 (es) 2009-01-02
RU2007127840A (ru) 2009-01-27
UY29306A1 (es) 2006-07-31
EP1888613A2 (de) 2008-02-20
AU2005324187A1 (en) 2006-07-13
MA29111B1 (fr) 2007-12-03
DK1888613T3 (da) 2009-03-30
EP1888613B1 (de) 2008-11-26
PT1888613E (pt) 2009-01-30
RS50726B (sr) 2010-08-31
RU2394835C2 (ru) 2010-07-20
HRP20090105T3 (en) 2009-03-31
KR20070089946A (ko) 2007-09-04

Similar Documents

Publication Publication Date Title
MY142807A (en) Benzimidazole derivative and use thereof.
DK0944617T3 (da) Krystaller af benzimidazolderivater og deres fremstilling
NO20064669L (no) Dipeptidylpeptidaseinhibitorer
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
NO20080157L (no) Fremgangsmate for syntese av organiske forbindelser
WO2008136444A1 (ja) 縮合複素環誘導体
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
IL192253A0 (en) Substituted cyclohexylmethyl derivatives
NO20053890L (no) Syntese av 4-amino-2-butenolklorider og anvendelse derav for fremstilling av 3-cyanokinoliner
NO20050418L (no) Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet
NO20074763L (no) (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi
NO20082116L (no) Kjemisk fremgangsmate for fremstilling av en amido-fenoksybenzosyreforbindelse
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
EA200701470A1 (ru) Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
NO20071253L (no) Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer.
NO20062936L (no) Fremgangsmate for fremstilling av N-alkyl-2(hydroksy-4-benzoyl)-3-benzofuraner og dets mellomprodukter derav
GB0215392D0 (en) Chemical compounds
NO20070972L (no) Benzyloksyderivater som MAOB-inhibitorer
NO20052023L (no) Kalsium aktivert K kanal apner med hoy konduktans
GB0003257D0 (en) Heterocyclic compounds and their therapeutic use
ATE488510T1 (de) Heterocyclische derivate, deren herstellung und therapeutische verwendung
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
EA200700767A1 (ru) Способ получения пиразолов

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application